
Liberate Bio
Developer of a genetic medicine technology designed to enable targeted delivery beyond the liver for broader therapeutic impact. The company offers a scalable system for extrahepatic delivery at indus...
Valuation
$0
Share Price
N/A
Total Raised
$31M
Last Round
N/A